Induction of epstein-barr virus (EBV) lytic cycle in vitro causes lipid peroxidation, protein oxidation and DNA damage in lymphoblastoid B cell lines

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Gargouri, Bochra ^a   Nasr, Rihab ^a   Mseddi, Malek ^a   Benmansour, Riadh ^a   Lassoued, Saloua ^a  

^a Université de Sfax   (Tunisia)

Author keywords

B95 8 cell line; Epstein Barr Virus; lymphoblastoid cell line; oxidative stress; Raji cell line

Indexed keywords

4 O METHYLPHORBOL 13 ACETATE 12 MYRISTATE; CARBONYL DERIVATIVE; DIENESTROL; MALONALDEHYDE; PROTEIN; PROTEIN CARBONYL; PROTEIN THIOL; THIOL; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE B95 8; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DNA OXIDATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS LYTIC CYCLE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID PEROXIDATION; LYMPHOBLASTOID CELL LINE; OXIDATION; OXIDATIVE STRESS; PROTEIN OXIDATION; RAJI CELL; VIRUS REPLICATION; ANIMAL; CALLITHRIX; CELL LINE; EPSTEIN BARR VIRUS INFECTION; METABOLISM; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PRE B LYMPHOCYTE; PROTEIN CARBONYLATION; VIROLOGY; VIRUS RELEASE;

HUMAN HERPESVIRUS 4;

ANIMALS; CALLITHRIX; CELL LINE; DNA DAMAGE; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; OXIDATION-REDUCTION; PRECURSOR CELLS, B-LYMPHOID; PROTEIN CARBONYLATION; VIRUS RELEASE;

EID: 79959758597     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-111     Document Type: Article

References (65)

1. Biology and disease associations of Epstein-Barr virus. DH Crawford, Philos Trans R Soc Lond B Biol Sci 2001 356 461 473 10.1098/rstb.2000.0783 11313005 (Pubitemid 32442746)
2. The B cell-immortalizing functions of Epstein-Barr virus. CJ Ring, J Gen Virol 1994 75 81
3. Epstein-Barr virus and its replication. E Kieff, Fields virology Lippincott-Raven Publishers, Philadelphia, Field BN, Knipe NM, Howley PM, et al, 3 1999
4. Persisting oncogenic herpes viruses induced by the tumor promoter TPA. H Zur Hausen F O'Neil U Freese, Nature 1978 272 373 375 10.1038/272373a0 204874 (Pubitemid 8308093)
5. Identification of a critical period during the S phase for activation of the Epstein-Barr virus by 5-iododeoxyuridine. B Hampar JG Derge LM Martos, Nat New Biol 1973 244 214 217 4353682
6. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. J Luka B Kallin G Klein, Virology 1979 94 228 231 10.1016/0042-6822(79)90455-0 220786 (Pubitemid 9164800)
7. Calcium modulation activates Epstein-Barr virus genome in latently infected cells. A Faggioni C Zompetta S Grimaldi, Science 1986 232 1554 1556 10.1126/science.3012779 3012779 (Pubitemid 16061565)
8. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. G Miller M Lipman, Proc Natl Acad Sci USA 1973 70 190 194 10.1073/pnas.70.1.190 4346033
9. Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease. T Spieker H Herbst, Am J Pathol 2000 1 51 57 (Pubitemid 30641724)
10. Epstein-Barr virus and Burkitt lymphoma. G Brady GJ Mac Arthur PJ Fanel, J Clin Pathol 2007 60 1397 1402 18042696 (Pubitemid 350247257)
11. Epstein-Barr virus and nasopharyngeal carcinoma. N Raab-traub, Semin Cancer Biol 1992 3 297 307 1335793
12. Epstein-Barr virus and gastric carcinoma. K Takada, EBV Rep 1999 6 95 100
13. The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. S Humme G Reisbach R Feederle, Proc Natl Acad Sci USA 2003 100 10989 10994 10.1073/pnas.1832776100 12947043 (Pubitemid 37140140)
14. Epstein-Barr virus-encoded poly (A) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. N Kitagawa M Goto K Kurozumi, EMBO J 2000 19 6742 6750 10.1093/emboj/19.24.6742 11118209 (Pubitemid 32011667)
15. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. B Tomkinson E Robertson E Kieff, J Virol 1993 67 2014 2025 8445720 (Pubitemid 23088375)
16. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease. KT Montone RL Hodinka KE Salhany, Mod Pathol 1996 9 621 630 8782198 (Pubitemid 26227562)
17. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Q Tao KD Robertson A Manns, Blood 1998 91 1373 1381 9454768 (Pubitemid 28086891)
18. Epstein-Barr virus infection contributes to lymphoproliferative disease in SCID mose model. GK Hong ML Gulley WH Feng, J Virol 2005 79 13993 14003 10.1128/JVI.79.22.13993-14003.2005 16254335 (Pubitemid 41552698)
19. Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: An update. E Toussirot J Roudier, Joint Bone Spine 2007 74 418 426 10.1016/j.jbspin.2007.05.001 17625943 (Pubitemid 47595467)
20. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. S Sarban A Kocyigit M Yazar, Clin Biochem 2005 38 981 986 10.1016/j.clinbiochem.2005.08.003 16150434 (Pubitemid 41606795)
21. Epstein- Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. G Niedobitek A Agathanggelou H Herbst, J Pathol 1997 182 151 159 10.1002/(SICI)1096- 9896(199706)182:2<151::AID-PATH8243.0.CO;2-3 9274524 (Pubitemid 27287835)
22. Oxidant production by human B lymphocytes: detection of activity and identification of components involved. TG Jones JD Wood, Methods 1996 9 619 627 10.1006/meth.1996.0068 8812716 (Pubitemid 26273480)
23. Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. F Cerimele T Battle R Lynch, Proc Natl Acad Sci USA 2005 102 175 179 10.1073/pnas.0408381102 15611471 (Pubitemid 40094448)
24. Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. S Lassoued R Ben Ameur Ayadi, Mol Cell Biochem 2008 313 179 186 10.1007/s11010-008-9755-z 18414998
25. Induction of Epstein-Barr virus (EBV) lytic cycle in vitro causes oxidative stress in lymphoblastoid B cell lines. B Gargouri Jos Van Pellt Abd El Fatteh El Feki Lassoued Saloua, Mol Cell Biochem 2008 324 55 63 19082543
26. Free radicals and antioxidants in normal physiological functions and human disease. M Valko D Leibfritz J Moncol, Int J Biochem Cell Biol 2007 39 44 84 10.1016/j.biocel.2006.07.001 16978905 (Pubitemid 44566469)
27. Quantification of protein modification by oxidants. Clare L Hawkins E Philip, Free Radical Biology Medicine 2009 46 965 988 10.1016/j.freeradbiomed. 2009.01.007 19439229
28. Oxidative damage to DNA: do we have a reliable biomarker? AR Collins M Dusinska CM Gedik, Environ Health Perspect 1996 04 465 469 (Pubitemid 26197677)
29. Measuring oxidative damage to DNA; HPLC and the comet assay compared. CM Gedik SG Wood AR Collins, Free Radic Res 1998 29 609 615 10.1080/ 10715769800300661 10098466 (Pubitemid 29112731)
30. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. AZ Reznick L Packer, Methods Enzymol 1994 233 357 363 8015470
31. Pathological aspects of active oxygens/free radicals. H Nakazawa C Genka M Fujishima, Jpn J Physiol 1996 46 15 32 10.2170/jjphysiol.46.15 8743715 (Pubitemid 26150396)
32. Protein carbonylation in human diseases. I Dalle-Donne D Giustarini R Colombo, Trends Mol Med 2003 9 169 76 10.1016/S1471-4914(03)00031-5 12727143 (Pubitemid 36626706)
33. Studies on the activity of DNase associated with the replication of the Epstein-Barr virus. C Yung-Chi, Virology 1980 100 334 338 10.1016/0042-6822(80) 90524-3 6243430
34. Express of plasma ROS, SOD and GSH-PX in patients with nasopharyngeal carcinoma. M Zhang L Liu L Cheng, Lin Chuang Er Bi Yan Hou Ke Za Zhi 2003 11 650 651
35. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. LA Ridnour JS Isenberg MG Espey, Proc Natl Acad Sci USA 2005 102 13152 13747
36. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies. R Ben Mansour S Lassoued A Elgaied S haddouk S Marzouk Z Bahloul M Hatam MS Aifa F Fakhfekh, Scand J Rheumatol 2010 39 247 253 10.3109/03009740903362511 20429675
37. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. G Miller M Lipman, Proc Natl Acad Sci USA 1973 70 190 194 10.1073/pnas.70.1.190 4346033
38. Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells. M Biggin M Bodescot M Perricaudet, J Virol 1987 61 3120 3132 3041034 (Pubitemid 17131493)
39. Characterization of an Epstein-Barr virus-induced thymidine kinase. M De Turenne-Tessier T Ooka G De The, J Virol 1986 57 1105 1112 3005613 (Pubitemid 16143994)
40. Effect of arabinofuranosylthymine on the replication of Epstein-Barr virus andrelationship with a new induced thymidine kinase activity. T Ooka A Calender M de Turenne, J Virol 1983 46 187 195 6298456 (Pubitemid 13161258)
41. Epstein-Barr virusspecific DNA polymerase in virus-nonproducer Raji cells. T Ooka G Lenoir G Decaussin, J Virol 1986 58 671 675 3009879 (Pubitemid 16013667)
42. Overexpression of inducible nitric oxide synthase and accumulation of 8-OHdG in nasopharyngeal carcinoma. Y Segawa Y Oda H Yamamoto, Histopathology 2008 52 213 223 18184270
43. Lipid Peroxidation and Antioxidant System in the Tumor and in the Blood of Patients with Nasopharyngeal Carcinoma. B Gargouri S Lassoued W Ayadi R ben Mansour H Attia A El fekih, Biol Trace Elem Res 2009
44. Epstein-Barr Virus Induces Fragmentation of Chromosomal DNA during Lytic Infection. K Michiko, J of virology 1993 3 7654 7658
45. DNA strand breaks, NAD metabolism, and programmed cell death. DA Carson S Seto DB Wasson, Exp Cell Res 1986 164 273 281 10.1016/0014-4827(86)90028-5 2940104 (Pubitemid 16042075)
46. Participation of p53 protein in the cellular response to DNA damage. D Li M Zeng J Wen, Cancer res 1991 23 6304 6311
47. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. RB Tishler SK Calderwood CN Coleman, Cancer Res 1993 53 2212 2216 8485705 (Pubitemid 23156801)
48. DNA dependant protein kinase acts upstream of P53 in reponse to DNA damage. RA Woo KG Mc Lure SP Lees Miller, Nature 1998 394 700 704 10.1038/29343 9716137 (Pubitemid 28389800)
49. Chambers TC Role of the stress-activated/c-Jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs. MT Osborn, J Biol Chem 1996 48 30950 30955
50. The DNA dependant protein kinase participates in the activation of NF kB following DNA damage. S Basu KR Rozenswei Youmell, Biochem Biophys Res Commun 1998 247 79 83 10.1006/bbrc.1998.8741 9636658 (Pubitemid 28412529)
51. Universal activation of NF kB by anticancer drugs in cancer cell lines. AL Cheng SE Chuang GM Lai, Proc Am Assoc Cancer Res 1998 39 1465
52. Reactive oxygen species and antioxidants in inflammatory diseases. ILC Chapple, J Clin Periodontol 1997 24 287 296 10.1111/j.1600-051X.1997.tb00760.x 9178107 (Pubitemid 127731526)
53. Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus. J Gosselin J Menezes M D'addario J Hiscott L Flamand G Lampoureux D Oth, Eur J Immunol 1991 21 203 208 10.1002/eji.1830210130 1846816
54. Inhibition of IFN-gamma signialing by EBV immediatle early protein. TE Morrison A Mauser A Wong JP Ting SC Kenney, Immunity 2001 15 787 799 10.1016/S1074-7613(01)00226-6 11728340
55. Interferon regulatory factor 7 is negatively regulated by EBV immediate-early gene, BZLF-1. AM Hahn LE Huye S Ning J Wzbster-Cyriaque JS Pagano, J Virol 2005 79 10040 10052 10.1128/JVI.79.15.10040-10052.2005 16014964 (Pubitemid 41022345)
56. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 alter mitochondrial morphology during lytic replication. DR LaJeunesse K Brooks Adamson, Biochem Biophys Res Commun 2005 333 438 442 10.1016/j.bbrc.2005.05.120 15950179 (Pubitemid 40848310)
57. EBV immunossuppression of innate immunity mediated by phagocytes. S Martin J Gosselin, Virus Research 2006 119 134 145 10.1016/j.virusres.2006.02. 008 16545476 (Pubitemid 43765988)
58. EBV infects and induces apoptosis in human neutrophils. B Larochelle L Flamand P Gourde D Beauchamp J Gosselin, Blood 1998 92 291 299 9639529 (Pubitemid 28303205)
59. Inhibition of 12-O-tetradecanoylphorbol-13-acetateinduced induction in epstein-barr virus early antigen in Raji cells. O Hitoshi Y Daisuke M Shigenobu, Cancer Letters 1983 19 47 53 10.1016/0304-3835(83)90134-9 6850568
60. Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors. WH Feng B Israel N Raab-Traub, Cancer Res 2002 62 1920 1926 11912175 (Pubitemid 34408523)
61. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies. EM Westphal W Blackstock W Feng, Cancer Res 2000 60 5781 5788 11059774
62. An efficient method for the rapid establishment of Epstein-Barr virus immortalization of human B lymphocytes. HM Oh JM Oh SC Choi, Cell Prolif 2003 36 191 197 10.1046/j.1365-2184.2003.00276.x 12950388
63. Free radical mediated peroxidative damage in systemic lupus erythematosus. BT Kurien RH Scofield, Life Sciences 2003 73 1655 1666 10.1016/S0024-3205(03)00475-2 12875898 (Pubitemid 36869006)
64. The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients. JR Palacio A Iborra Z Ulcova-Gallova, Clin Exp Immunol 2006 144 217 222 10.1111/j.1365-2249.2006.03061.x 16634794
65. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. W Ju-Hyung K Young-Ho C Yun-Jung, Carcinogenesis 2003 7 1199 1208